221 related articles for article (PubMed ID: 9679967)
21. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters.
Hashimura T; Kanamaru H; Yoshida O
Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059
[TBL] [Abstract][Full Text] [Related]
22. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
23. Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis.
Hattori K; Iida K; Joraku A; Tsukamoto S; Akaza H; Oyasu R
BJU Int; 2006 Mar; 97(3):640-3. PubMed ID: 16469040
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
Kuno T; Hirose Y; Yamada Y; Hata K; Qiang SH; Asano N; Oyama T; Zhi H; Iwasaki T; Kobayashi H; Mori H
Oncol Rep; 2006 Mar; 15(3):533-8. PubMed ID: 16465408
[TBL] [Abstract][Full Text] [Related]
25. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
[TBL] [Abstract][Full Text] [Related]
26. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
Okajima E; Hiramatsu T; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Tanaka M; Maruyama Y
Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898
[TBL] [Abstract][Full Text] [Related]
27. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
28. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
Irving CC; Murphy WM; Daniel DS
J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ
Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
33. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
34. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
[TBL] [Abstract][Full Text] [Related]
35. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Masuda C; Wanibuchi H; Sekine K; Yano Y; Otani S; Kishimoto T; Tsuda H; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):582-8. PubMed ID: 10874209
[TBL] [Abstract][Full Text] [Related]
36. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder tumor in rats by alpha-difluoromethylornithine.
Kawahara M; Matsuhashi T; Yagishita T; Tajima M; Matsushima M
Hinyokika Kiyo; 1987 Jan; 33(1):27-30. PubMed ID: 3107357
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.
Homma Y; Kakizoe T; Samma S; Oyasu R
Cancer Res; 1987 Dec; 47(23):6176-9. PubMed ID: 3119193
[TBL] [Abstract][Full Text] [Related]
39. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
Miyakawa M; Yoshida O
Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine initiation.
Okajima E; Tsutsumi M; Ozono S; Akai H; Denda A; Nishino H; Oshima S; Sakamoto H; Konishi Y
Jpn J Cancer Res; 1998 Jan; 89(1):22-6. PubMed ID: 9510471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
